Cardiovascular
Category VIEW ALL
Method for Quantification of Lipoprotein(a)
The innovation offers a reference method for the quantification of lipoprotein(a) in clinical and research applications and serves to broaden the use of Lp(a) as a biomarker in cardiovascular disease outcome measurement and risk assessment.
TBD
Targeting von Willebrand Factor to Model Disease in Human Pluripotent Stem Cells
The disclosed technology offers a CRISPR-Cas9 generated, isogenic hPSC-EC in-vitro model for studying disease dynamics and therapeutic candidates for VWF-deficient diseases such as Von Willebrand disease (VWD).
TBD